A modified bone morphogenetic protein (BMP, also referred to as bone morphogenic protein) composition is described.
A preferred bone morphogenic protein is BMP-2.
The present invention particularly relates to a synthetic composition, comprising BMP-2 (bone morphogenetic protein-2), BMP-4 (bone morphogenetic protein-4), activin A and ascorbic acid.
Novel genetic variants of the Bone Morphogenetic Protein Receptor, Type II (Serine/Threonine Kinase) (BMPR2) gene are described.
The anti-tumor agent contains bone morphogenetic protein BMP4 as an active ingredient.
A method of preparing bone morphogenetic fusion protein comprises purifying and renaturing bone morphogenetic protein to provide an active bone morphogenetic fusion protein preparation.
The injected material may be a bone graft or a bone graft substitute (e.g., bone morphogenetic protein).
Chondrocytes, when cultured in this medium in the presence of a cartilage derived morphogenetic protein or bone morphogenetic protein, retain their cartilaginous phenotype.
The osteointegration material of the sleeve may be, for example, allograft bone or a bone growth material such as bone morphogenetic protein.
Preferred methods comprise administering a composition containing a bone morphogenetic protein and a suitable carrier.
The transfected periosteal cells then express the bone morphogenic protein in culture to promote bone repair as a function of the expressed bone morphogenic protein.
Methods of use of the bone morphogenetic fusion protein are also provided.
A bone morphogenetic fusion protein and a method of preparation of the bone morphogenetic fusion protein.
For example, the therapeutic protein can be a bone morphogenic protein when the tissue to be treated is bone tissue.
The bone modulating drug may be chosen from bisphosphonates, statins, growth factors, signaling proteins and bone morphogenic protein.
Including a bone morphogenic protein during the differentiation process enhances the ability of the cell population to form secondary colonies.
The present invention provides methods and compositions for treating and repairing ligament defects using a bone morphogenic protein.
The invention also includes osteoinductive compositions including the carriers and an effective amount of a bone morphogenetic protein dispersed within the ceramic.
Disclosed herein is an osteogenic synthetic peptide, derived from bone morphogenet i c protein-7, consisting of a sequence of 15 amino acid residues (BFP 1).
The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human BMP polypeptides.
The present invention provides bone morphogenetic protein receptor (BMPR) binding agents, such as antibodies, and compositions comprising said binding agents.
The invention further relates to compositions including a protease and a growth factor comprising a bone morphogenic protein (BMP) or a variant thereof.
The present invention relates to novel human BMP polypeptides and isolated nucleic acids containing the coding regions of the genes encoding such polypeptides.
Activity tests in vitro have shown that the compound of the present invention shows an obvious upregulation effect on bone morphogenetic protein BMP-2.
Two of the most important bone growth factors are platelet-derived growth factor (PDGF) and bone morphogenetic protein 2 (BMP-2).
Requêtes fréquentes français :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Requêtes fréquentes anglais :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Traduction Translation Traducción Übersetzung Tradução Traduzione Traducere Vertaling Tłumaczenie Mετάφραση Oversættelse Översättning Käännös Aistriúchán Traduzzjoni Prevajanje Vertimas Tõlge Preklad Fordítás Tulkojumi Превод Překlad Prijevod 翻訳 번역 翻译 Перевод